Biotech Values

[jessellivermore]

Dear Trond..

Forgive my lack of clarity. I was using "marginal" in a subjective sense when what I should of said is Provenge is not a cure.

My post was pretty spur of the moment. I have a little more time at present and will attempt to clarify my scepticism.

DNDN has stated they will charge somewhere in the $90K range for their treatment..This brings me back to Tissue Repair I seem to remember (Dew may have notes) TR was planning on charging a more modest $20K for their cartiledge cure. There were lots of bum knees running around..whoops, perhaps not running. The potential revenues were staggering...Then Blue Shield after stalling for about nine months simply decided they were not convinced, despite FDA OK, the treatment was beneficial, and refused to cover the treatment. There was some bickering in the Orthopedic field.. but without insurance paying for this the company's PPS went into a steady decline...

If I catch the drift of the governments Patient Protection Act, I do not see them wasting resources on this very expensive treatment. You can forget about Europe, Asia and Africa, they are still trying to combat more important issues. This is Gucci Medicine... If you want it most people would have to sell their house...I predict they do not sell the house...